Impact
Measurable clinical outcomes
Our products are clinically validated, resulting in measurable patient outcomes.
Significant reduction in caesarean sections
[(27/101, 26.7%) in GDm-Health group versus (47/102, 46.1%) in the control group, P=.005]1
Reduction in pre-term births
[(5/101, 5.0%) in GDm-Health group versus (13/102, 12.7%; OR 0.36, 95% CI 0.12-1.01) in the control group]1
Significantly higher overall health status
[5-level EuroQol 5-dimension questionnaire, mean score increased in the EDGE-COPD group by 0.01 and decreased in the standard care arm by 0.08, P=.003]2
Our presence
Our product adoption and Strategic Research Agreement data footprint
GDm-Health
Population served
Patients monitored
SEND
Population served
Patients monitored
Strategic Research
Agreement
Patient records
Data Access
Agreement
Patient records
Satisfaction
Analysing results from clinical trials and observational studies to improve patient outcomes. Our products meet the needs of both patients and clinicians.
Analysing results from clinical trials and observational studies to improve patient outcomes. Our products meet the needs of both patients and clinicians.
Users of GDm-HealthTM app would recommend the app to their family and friends1
Providing time to care and saving costs
Our products help to make clinicians more efficient, allowing them more time to spend with their patients. They also reduce the number of unnecessary clinical visits, driving costs down for healthcare providers.
Saving per patient using GDm-Health3
Reduction in the number of visits to see practice nurses for COPD patients using the EDGE-COPD app2
Reduction in time spent on clerical and administrative tasks when using GDm-Health3
Reduction in the time to take a set of vital sign observations when using SEND4
Compliance
The design of our products has been led by clinicians, helping to improve patient compliance and medication adherence.
Significantly better adherence to blood glucose monitoring
[mean 3.80 readings per day, (SD 1.80) in the GDm-Health group and mean 2.63 readings per day, (SD 1.71) in the control group (P=1)
High compliance for COPD monitoring
[EDGE-COPD patients submitted symptoms and oxygen saturations 5.9 days per week and completed their diaries within 2 hours of their chosen time.]2
References
1. Mackillop, L., Hirst, J.E., Bartlett, K.J., Birks, J.S., Clifton, L., Farmer, A.J., Gibson, O., Kenworthy, Y., Levy, J.C., Loerup, L. and Rivero-Arias, O., 2018. Comparing the Efficacy of a Mobile Phone-Based Blood Glucose Management System With Standard Clinic Care in Women With Gestational Diabetes: Randomized Controlled Trial. JMIR mHealth and uHealth, 6(3), p.e71.
2. Farmer, A., Williams, V., Velardo, C., Shah, S.A., Yu, L.M., Rutter, H., Jones, L., Williams, N., Heneghan, C., Price, J. and Hardinge, M., 2017. Self-Management support using a digital health system compared with usual care for chronic obstructive pulmonary disease: randomized controlled trial. Journal of medical Internet research, 19(5).
3. National Institute for Clinical Excellence (2017) Health app: GDm-Health for people with gestational diabetes. Medtech innovation briefing (MIB131).
4. Wong, D., Bonnici, T., Knight, J., Gerry, S., Turton, J. and Watkinson, P., 2017. A ward-based time study of paper and electronic documentation for recording vital sign observations. Journal of the American Medical Informatics Association, 24(4), pp.717-721.
